From: Effect of chronic kidney disease on outcomes of total joint arthroplasty: a meta-analysis
Author | Year | Country | Study design | Database | Type of surgery | Mean age (years) | Total sample size | CKD stage | Number of cases in CKD group | Number of cases in control group | NOS |
---|---|---|---|---|---|---|---|---|---|---|---|
Bedard [27] | 2018 | USA | Retrospective case–control | Humana database | THA | N/A | 17,695 | N/A | 2288 | 15,407 | 6 |
Bedard [28] | 2018 | USA | Retrospective case–control | Humana database | TKA | N/A | 35,894 | N/A | 4551 | 31,343 | 6 |
Boniello [29] | 2018 | USA | Retrospective cohort study | ACS-NSQIP | THA | ≥ 80 |  | Preop Cr > 1.5 mg/L | 1759 | 65,080 | 7 |
Cavanaugh [30] | 2016 | USA | Retrospective cohort study | NIS | THA, TKA | CKD: 71.9 non-CKD: 65.6 | 1,014,686 | CKD stage 3–4, RT, dialysis, and ESRD | 36,308 | 978,378 | 7 |
Deegan [21] | 2014 | USA | Retrospective cohort study | Geisinger Health System | THA, TKA | 72 | 779 | CKD stage 1, 2, 3 | 402 | 377 | 8 |
Erkocak [15] | 2016 | USA | Retrospective cohort study | Hospital data | THA, TKA | CKD: 67.8 Control: 67.2 | 1077 | N/A | 359 | 718 | 8 |
Kildow [31] | 2017 | USA | Retrospective cohort study | Medicare | THA | N/A | 91,467 | CKD stage 1–4, hemodialysis, RT | 29,689 | 61,778 | 8 |
Kuo [33] | 2017 | Taiwan | Retrospective cohort study | Hospital data | TKA | CKD: 72.1 Non-CKD: 71.0 | 615 | eGFR < 60 | 205 | 410 | 8 |
Kuo [22] | 2017 | Taiwan | Retrospective cohort study | NHIRD | TKA | CKD: 71.6 Non-CKD: 70.3 | 13,844 | N/A | 1459 | 12,385 | 8 |
Lizaur-Utrilla [34] | 2016 | Spain | Retrospective case–control | Hospital data | TKA | ESRD: 69.3 Control: 70.1 | 45 | ESRD (dialysis or RT) | 15 | 30 | 7 |
Marya [35] | 2016 | India | Retrospective case–control | Hospital data | Bilateral simultaneous TKA | 65.8 | 556 | Moderate-to-severe renal disease | 11 | N/A | 7 |
McCleery [32] | 2010 | UK | Retrospective cohort study | Scottish Arthroplasty Project | TKA | N/A | 59,288 | Renal failure, RT, dialysis | 3718 | N/A | 7 |
Miric [23] | 2014 | USA | Retrospective cohort study | TJRR | THA | 66 | 18,663 | CKD stage 3, 4, 5 | 1269 | 17,394 | 8 |
Miric [24] | 2014 | USA | Retrospective cohort study | TJRR | TKA | 67 | 37,482 | CKD stage 3, 4, 5 | 2686 | 34,796 | 8 |
Nikkinen [36] | 2019 | Finland | Retrospective cohort study | Hospital data | THA, TKA | Moderated to severe CKD: 81 Mild CKD: 77 Normal kidney function: 71 | 807 | eGFR < 60 | 109 | 698 | 7 |
Patterson [25] | 2018 | USA | Retrospective cohort study | ACS-NSQIP | THA, TKA | N/A | THA:129370 TKA:214005 | Dialysis | THA:306 TKA:339 | THA:129064 TKA:213666 | 8 |
Ponnusamy [26] | 2015 | USA | Retrospective cohort study | NIS | THA, TKA | - THA Non-dialysis: 65.2 Dialysis: 63.2 - TKA Non-dialysis: 66.8 Dialysis: 66.7 | THA: 2006522 TKA: 4182887 | ESRD | THA:1251 TKA: 1683 | THA: 2005271 TKA: 4181204 | 7 |
Warth [14] | 2015 | USA | Retrospective cohort study | ACS NSQIP | THA, TKA | Mild or normal CKD: 70.7 Moderate or severe CKD: 72.6 | 25,116 | eGFR < 60 | 12,558 | 12,558 | 8 |